EUVIMEDEUVIMED entdecken
Crossref

Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease

Shun-Ichi Wakabayashi, Nobuharu Tamaki, Takefumi Kimura, Takeji Umemura, Masayuki Kurosaki, Namiki Izumi

Journal of Gastroenterology · 2024-06 · 59 (6) · 494-503

DOI: 10.1007/s00535-024-02093-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 04.04.2024. Verfasst von Shun-Ichi Wakabayashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Nagano, Japan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Conflicting evidence regarding the prognosis of lean metabolic dysfunction-associated steatotic liver disease (MASLD) has raised substantial questions. AIM: This study aimed to elucidate the prognosis of lean MASLD by conducting a comprehensive analysis of a vast Asian cohort. METHODS: This study used a nationwide, population-based database and analyzed 2.9 million patients. The primary endpoints were liver-related events (LREs) and cardiovascular events (CVEs) in patients with lean MASLD, non-lean MASLD, and normal liver control groups. RESULTS: The median observation period was 4.2 years. The 5-year incidence values of LREs in the lean MASLD, non-lean MASLD, and normal liver control groups were 0.065%, 0.039%, and 0.006%, respectively. The LRE risk of lean MASLD was significantly higher than that of normal liver control (adjusted hazard ratio [aHR]: 5.94, 95% confidence interval [CI]: 3.95-8.92) but comparable to that of non-lean MASLD (aHR: 1.35, 95% CI: 0.87-2.08). By contrast, for CVEs, the non-lean MASLD group exhibited a higher 5-year cumulative incidence rate (0.779%) than the lean MASLD (0.600%) and normal liver control (0.254%) groups. The lean MASLD group had a reduced risk of CVEs compared with the non-lean MASLD group (aHR, 0.73; 95% CI: 0.64-0.84), and comparable risk of CVEs to the normal liver control group (aHR, 0.99; 95% CI: 0.88-1.12). CONCLUSION: Lean MASLD exhibits a similar LRE risk and a lower CVE risk to non-lean MASLD. Therefore, follow-up and treatment strategies should be tailored to the specific MASLD condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseHumansMaleFemaleMiddle AgedIncidencePrognosisAdultAgedCardiovascular DiseasesRisk FactorsDatabases, FactualThinnessFatty Liver

Stichwörter der Autor:innen

Cardiovascular eventLean MASLDLiver-related eventMetabolic dysfunction-associated steatotic liver disease (MASLD)

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, Shinshu University School of Medicine, Nagano, Japan.
  • Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, 1-26-1 Kyonan-Cho, Musashino-Shi, Tokyo, 180-8610, Japan.
  • Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, 1-26-1 Kyonan-Cho, Musashino-Shi, Tokyo, 180-8610, Japan. kurosaki@musashino.jrc.or.jp.

Förderung

  • Japan Agency for Medical Research and Development
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Wakabayashi, S. I., Tamaki, N., Kimura, T., Umemura, T., Kurosaki, M., & Izumi, N. (2024). Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease. Journal of Gastroenterology, 59(6), 494-503. https://doi.org/10.1007/s00535-024-02093-z

Vancouver

Wakabayashi SI, Tamaki N, Kimura T, Umemura T, Kurosaki M, Izumi N. Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease. Journal of Gastroenterology. 2024;59(6):494-503. doi:10.1007/s00535-024-02093-z

BibTeX
@article{Wakabayashi2024,
  author = {Wakabayashi, Shun-Ichi and Tamaki, Nobuharu and Kimura, Takefumi and Umemura, Takeji and Kurosaki, Masayuki and Izumi, Namiki},
  title = {Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease},
  journal = {Journal of Gastroenterology},
  year = {2024},
  volume = {59},
  number = {6},
  pages = {494--503},
  doi = {10.1007/s00535-024-02093-z}
}
Kostenlos starten →